Literature DB >> 11039132

Improved dysgammaglobulinaemia in congenital rubella syndrome after immunoglobulin therapy: correlation with CD154 expression.

N Kawamura1, A Okamura, H Furuta, S Katow, M Yamada, I Kobayashi, M Okano, K Kobayashi, Y Sakiyama.   

Abstract

UNLABELLED: A boy with congenital rubella syndrome developed dysgammaglobulinaemia with elevated serum levels of IgM. CD154 was not induced on his peripheral blood mononuclear cells when rubella virus RNA was detected in his throat swabs and peripheral blood by reverse transcriptase polymerase chain reaction. Following intravenous immunoglobulin therapy, improvement of immunoglobulin abnormalities, disappearance of rubella virus and normalisation of CD154 expression were demonstrated.
CONCLUSION: These findings implicate the efficacy of intravenous immunoglobulin therapy for dysgammaglobulinaemia in congenital rubella syndrome and a role of CD154 for a prolonged virus infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039132     DOI: 10.1007/pl00008342

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  2 in total

1.  Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection.

Authors:  Rohan Ameratunga; See-Tarn Woon; Wikke Koopmans; John French
Journal:  J Clin Immunol       Date:  2008-07-29       Impact factor: 8.317

Review 2.  Immunoglobulin class-switch recombination deficiencies.

Authors:  Anne Durandy; Sven Kracker
Journal:  Arthritis Res Ther       Date:  2012-07-30       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.